Bioxcel Therapeutics(DE:BX20)
€0.070.00 (0.00%)
DE:BX20
Bioxcel Therapeutics earnings date
€0.07
At close:0.00 (0.00%)
Bioxcel Therapeutics (BX20) Q2 2026 Earnings Report
10 Followers
DE:BX20 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.44
- Consensus EPS
- -EUR 0.40
- Beat/Miss
- Missed by -EUR 0.04
- One Year Ago EPS
- -EUR 2.23
DE:BX20 Q2 2026 Revenue Results
- Actual Revenue
- EUR 165.91K
- Expected Revenue
- EUR 442.12K
- Beat/Miss
- Missed by -EUR 276.21K
- YoY Revenue Growth
- +51.67%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/11/2026
- Time
- TBA
- Conference Call
- Tuesday, August 11, 2026
DE:BX20 Upcoming Earnings
Bioxcel Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BX20 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | ―- | -0.53 | ― | ― |
| Nov 18, 2026 | 2026 (Q3) | -0.92- | -1.99 | ― | |
| Aug 11, 2026 | 2026 (Q2) | -0.40-0.44 | -2.23 | 80.16% (+1.79) | |
| May 15, 2026 | 2026 (Q1) | -0.48-0.49 | -1.37 | 64.00% (+0.88) | |
| Mar 27, 2026 | 2025 (Q4) | -0.58-0.53 | -3.25 | 83.75% (+2.73) | |
| Nov 12, 2025 | 2025 (Q3) | -1.22-1.99 | -4.67 | 57.42% (+2.68) | |
| Aug 12, 2025 | 2025 (Q2) | -1.69-2.23 | -3.06 | 27.08% (+0.83) | |
| May 12, 2025 | 2025 (Q1) | -2.48-1.37 | -12.69 | 89.22% (+11.32) | |
| Mar 27, 2025 | 2024 (Q4) | -5.51-3.25 | -11.08 | 70.64% (+7.83) | |
| Nov 14, 2024 | 2024 (Q3) | -7.37-4.67 | -25.09 | 81.40% (+20.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

